BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26800999)

  • 1. Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy.
    Kim JG; Song KD; Kim SH; Kim HC; Huh JW
    J Magn Reson Imaging; 2016 Aug; 44(2):471-7. PubMed ID: 26800999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.
    Huang SH; Chi P; Lin HM; Lu XR; Huang YW; Xu ZB; Sun YW; Ye DX; Wang XJ; Wang X
    Colorectal Dis; 2016 Oct; 18(10):989-996. PubMed ID: 26880193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumor regression grade and clinical stage based on MRI image as a selection criterion for non-radical management after concurrent chemoradiotherapy in locally advanced rectal cancer: a multicenter, retrospective, cross-sectional study.
    Yang IJ; Suh JW; Lee J; Ahn HM; Oh HK; Kim DW; Kim MJ; Ryoo SB; Jeong SY; Park KJ; Lee DW; Park SC; Park HC; Oh JH; Kang SB
    Int J Colorectal Dis; 2022 Jul; 37(7):1561-1568. PubMed ID: 35648208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?
    Dresen RC; Beets GL; Rutten HJ; Engelen SM; Lahaye MJ; Vliegen RF; de Bruïne AP; Kessels AG; Lammering G; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):71-80. PubMed ID: 19403847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
    Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
    Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
    Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer?
    Joye I; Debucquoy A; Fieuws S; Wolthuis A; Sagaert X; D'Hoore A; Haustermans K
    Acta Oncol; 2016 Aug; 55(8):1047-52. PubMed ID: 27142064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.
    Wan J; Liu K; Zhu J; Li G; Zhang Z
    Oncotarget; 2015 May; 6(13):11714-22. PubMed ID: 25909169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer.
    Joye I; Debucquoy A; Deroose CM; Vandecaveye V; Cutsem EV; Wolthuis A; D'Hoore A; Sagaert X; Zhou M; Gevaert O; Haustermans K
    Radiother Oncol; 2017 Jul; 124(1):104-109. PubMed ID: 28647399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
    Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
    Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.
    Wang Y; Wang X; Huang S; Chen J; Huang Y
    ANZ J Surg; 2024 Jun; 94(6):1127-1132. PubMed ID: 38251776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
    Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
    Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.